AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
MUMBAI, May 1 Asia Pulse - Nectar Lifesciences (BSE:532649), an active pharmaceutical ingredient maker, will be setting up two manufacturing facilities at Baddi in Himachal Pradesh, for an investment of Rs 750 million (US$18.3 million).
Many companies are setting up/relocating their operations in Baddi, located in the Solan district of the state, to take advantage of the tax and excise concessions offered by the state and central government.
Nectar's Baddi facilities -- Cephalosporin Formulation Unit and Empty Hard Gelatin Capsule Unit -- have been funded by Initial Public ...